Astrazeneca (AZN) Profit Margin (2006 - 2026)
Astrazeneca (AZN) profit margin from Mar 31, 2006 to Mar 31, 2026. The current Astrazeneca (AZN) profit margin is 20.15%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Astrazeneca (AZN)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 17.46% | +34.19% |
| 2024 | 13.01% | +0.09% |
| 2023 | 13.00% | +75.34% |
| 2022 | 7.41% | +2376.73% |
| 2021 | 0.30% | -97.51% |
| 2020 | 12.01% | +119.32% |
| 2019 | 5.47% | -43.88% |
| 2018 | 9.76% | -26.97% |
| 2017 | 13.36% | -12.18% |
| 2016 | 15.21% | +33.04% |
| 2015 | 11.43% | +146.17% |
| 2014 | 4.64% | -53.11% |
| 2013 | 9.90% | -55.60% |
| 2012 | 22.31% | -24.44% |
| 2011 | 29.52% | +21.97% |
| 2010 | 24.21% | +5.58% |
| 2009 | 22.93% | +18.75% |
| 2008 | 19.31% | +2.00% |
| 2007 | 18.93% | -17.07% |
| 2006 | 22.83% | N/A |
Comparison Astrazeneca (AZN) profit margin with competitors
Astrazeneca (AZN) profit margin is 20.15%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 50.15% | +148.93% |
| LLY | Lilly(Eli) & Company | 37.36% | +85.44% |
| GILD | Gilead Sciences Inc | 29.04% | +44.14% |
| NVS | Novartis AG | 23.34% | +15.85% |
| BMY | Bristol-Myers Squibb Company | 23.30% | +15.65% |
| GSK | GSK Plc | 22.77% | +13.02% |
| JNJ | Johnson & Johnson | 21.76% | +8.01% |
| AMGN | AMGEN Inc | 21.11% | +4.78% |
| PFE | Pfizer Inc | 18.59% | -7.73% |
| SNY | Sanofi | 14.35% | -28.77% |
| BIIB | Biogen Inc | 12.89% | -36.02% |
| OGN | Organon & Company | 10.00% | -50.36% |
| ABBV | Abbvie Inc | 4.63% | -77.02% |
| GRFS | Grifols SA | 4.29% | -78.71% |